The original success of Sildenafil undeniably reshaped the medication landscape, but placing funds in companies primarily reliant on off-patent versions presents a complex picture. While early profits were impressive, https://pharma862517.techionblog.com/42085170/sildenafil-and-big-pharma-a-risky-bet